Putting Higher Education Within Reach for Partners Employees
Partners HealthCare employees have a new pathway to advance their education, thanks to an expansion of a partnership with Southern New Hampshire University. The initiative builds on the accredited, nonprofit College for America program at SNHU, which has already helped more than 400 Partners employees.
Investigating Artificial Intelligence at the World Medical Innovation Forum
“This is what I call rock star city,” Massachusetts Governor Charlie Baker told the 1,700 participants gathered at the World Medical Innovation Forum, recently hosted by Partners HealthCare. “I’ve never seen such a terrific collection of intellectual capital.”
Meet Your Microbes, and Climb Inside an Iron Lung: A Celebration of Science in Cambridge
Moving discovery from the region’s institutions into the community—that is the goal of the Cambridge Science Festival, a unique 10-day celebration of science, technology, engineering, art, and math. Partners HealthCare hospitals played a key role in helping the festival’s attendees understand the many ways that medical science impacts their lives.
Personalizing Medicine, at the Cellular Level
Much of the work underway in Partners HealthCare’s research laboratories is aimed not only toward elucidating new treatments for specific conditions, but toward fostering better understanding of the basic science that underpins medicine and health care more broadly.
Setting Our Sights on Artificial Intelligence
Artificial intelligence (AI) will be the talk of the town when over 1,500 health care stakeholders—clinicians, industry executives, researchers, investors, and policymakers—gather in Boston next week at the 2018 World Medical Innovation Forum, hosted by Partners HealthCare.
Fueled by Complexity, Research Yields New Hope for Epilepsy
Ellen J. Bubrick, MD, has never shied from complexity—in fact, that’s what drew the Brigham and Women’s Hospital researcher and epilepsy surgery program director to neurology in the first place. Complexity led Dr. Bubrick to target her research toward helping patients with uncontrolled epilepsy that is unresponsive to conventional treatment.